These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Blum HE; Galun E; von Weizsäcker F; Wands JR Lancet; 1991 May; 337(8751):1230. PubMed ID: 1673773 [No Abstract] [Full Text] [Related]
5. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay. Seki M; Honda Y J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414 [TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides. Moriya K; Matsukura M; Kurokawa K; Koike K Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134 [TBL] [Abstract][Full Text] [Related]
8. Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implications. Rothenberg M; Johnson G; Laughlin C; Green I; Cradock J; Sarver N; Cohen JS J Natl Cancer Inst; 1989 Oct; 81(20):1539-44. PubMed ID: 2677394 [No Abstract] [Full Text] [Related]
9. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression. Hung WC; Huang JS; Chuang LY Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831 [TBL] [Abstract][Full Text] [Related]
10. Does antisense make sense? Beijnen JH Pharm World Sci; 1993 Oct; 15(5):185. PubMed ID: 8257953 [No Abstract] [Full Text] [Related]
11. Sequence-specific inhibition of the tumor necrosis factor-alpha receptor I gene by oligodeoxynucleotides containing N7 modified 2'-deoxyguanosine. Ojwang JO; Lewis AF; Revankar GR; Walker D; Akiyama T; Hogan ME; Rando RF Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):447-59. PubMed ID: 9361904 [TBL] [Abstract][Full Text] [Related]
12. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides. Wingens M; Pfundt R; van Vlijmen-Willems IM; van Hooijdonk CA; van Erp PE; Schalkwijk J Lab Invest; 1999 Nov; 79(11):1415-24. PubMed ID: 10576212 [TBL] [Abstract][Full Text] [Related]
13. Elucidating cell signaling mechanisms using antisense technology. Koller E; Gaarde WA; Monia BP Trends Pharmacol Sci; 2000 Apr; 21(4):142-8. PubMed ID: 10740290 [TBL] [Abstract][Full Text] [Related]
14. The state of the art in antisense research. Wagner RW Nat Med; 1995 Nov; 1(11):1116-8. PubMed ID: 7584973 [No Abstract] [Full Text] [Related]